SoftOx Solutions AS
OSE:SOFTX
Net Margin
SoftOx Solutions AS
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| NO |
S
|
SoftOx Solutions AS
OSE:SOFTX
|
196.7m NOK |
-543%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
722.9B USD |
23%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
360.3B USD |
24%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK |
35%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
206.2B CHF |
14%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
185.9B CHF |
24%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
161.1B GBP |
14%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
198.9B USD |
27%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
-126%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
136.3B USD |
13%
|
SoftOx Solutions AS
Glance View
SoftOx Solutions AS engages in research and product development. The company is headquartered in Fornebu, Akershus. The company went IPO on 2018-06-01. The company is a developer of infection control solutions for disinfection, wound care and the respiratory tract. The current business segments can be divided into: Wounds, Disinfection and Respiratory. SoftOx Solutions is engaged in the development of a range of products that can be classified as either medical devices or medicinal products for human use. SoftOx’s product portfolio includes such products as SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin. The firm has several subsidiaries, including SoftOx Disinfection AS, SoftOx Defense Solutions AS and SoftOx Denmark AS.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on SoftOx Solutions AS's most recent financial statements, the company has Net Margin of -542.6%.
You don't have any saved screeners yet